Source Natural

34
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE679C01027
  • NSEID:
  • BSEID: 531398
INR
107.40
-1.1 (-1.01%)
BSENSE

Oct 01, 03:30 PM

BSE+NSE Vol: 1.29 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 56.66% vs 64.57% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 31.52% vs 0.26% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 5.03% vs 199.38% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 17.06% vs 67.23% in Mar 2025

Compare Profit and Loss Results of Source Natural
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
70.00
87.00
-17.00
-19.54%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
70.00
87.00
-17.00
-19.54%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-1.00
1.00
100.00%
Raw Materials Consumed
55.00
32.00
23.00
71.88%
Power & Fuel Cost
0.00
8.00
-8.00
-100.00%
Employee Cost
4.00
12.00
-8.00
-66.67%
Operating Expenses
0.00
6.00
-6.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
6.00
-6.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
4.00
-4.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
64.00
73.00
-9.00
-12.33%
Operating Profit (PBDIT) excl Other Income
5.00
13.00
-8.00
-61.54%
Other Income
0.00
1.00
-1.00
-100.00%
Operating Profit (PBDIT)
5.00
15.00
-10.00
-66.67%
Interest
0.00
6.00
-6.00
-100.00%
Profit before Depriciation and Tax
5.00
8.00
-3.00
-37.50%
Depreciation
0.00
6.00
-6.00
-100.00%
Profit Before Taxation & Exceptional Items
4.00
2.00
2.00
100.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
4.00
-7.00
11.00
157.14%
Provision for Tax
1.00
-1.00
2.00
200.00%
Profit After Tax
3.00
-5.00
8.00
160.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
14.00
46.00
-32.00
-69.57%
Profit Available for appropriations
18.00
41.00
-23.00
-56.10%
Appropriations
18.00
41.00
-23.00
-56.10%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
5.28
-5.17
10.45
202.13%
Profit And Loss - Net Sales
Net Sales 70.38 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 56.66% vs 64.57% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5.90 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 31.52% vs 0.26% in Mar 2025

Profit And Loss - Interest
Interest 0.66 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 5.03% vs 199.38% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 3.40 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 17.06% vs 67.23% in Mar 2025

Footer loading